Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX)-Reference-Cited by-同舟云学术

Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX)

Published:2007 Issue:3 Volume:110 Page:670-677
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Ashley Amanda C.,Sargent Daniel J.,Alberts Steven R.,Grothey Axel,Campbell Megan E.,Morton Roscoe F.,Fuchs Charles S.,Ramanathan Ramesh K.,Williamson Stephen K.,Findlay Brian P.,Pitot Henry C.,Goldberg Richard M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference18 articles.

1. Cancer Statistics, 2006

2. The triplet combination of irinotecan, oxaliplatin and 5FU/LV (FOLFOXIRI) vs the doublet of irinotecan and 5FU/LV (FOLFIRI) as first-line treatment of metastatic colorectal cancer (MCRC): Results of a randomized phase III trial by the Gruppo Oncologico Nord Ovest (G.O.N.O.)

3. A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

4. Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741

5. . Topoisomerase I-targeting drugs. In: , eds. Cancer Chemotherapy and Biotherapy: Principles and Practice. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2006: 371–413.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcome Multidrug Resistance in Colorectal Cancer by Natural Compounds;Science of Advanced Materials;2020-07-01

2. Amifostine protects from the peripheral sensory neuropathy induced by oxaliplatin in mice;Brazilian Journal of Medical and Biological Research;2020

3. An Update on Randomized Clinical Trials in Metastatic Colorectal Carcinoma;Surgical Oncology Clinics of North America;2017-10

4. Evaluation of cytotoxic effect of the combination of a pyridinyl carboxamide derivative and oxaliplatin on NCI-H1299 human non-small cell lung carcinoma cells;Biomedicine & Pharmacotherapy;2016-12

5. Review of systemic therapies for locally advanced and metastatic rectal cancer;J GASTROINTEST ONCOL;2015